Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.

The most recent subcohort index dates showed a trend for decreasing time to intensification, although there was a slight increase between the cohorts 1 January 2006 to 31 December 2008 and 1 January 2009 to 30 June 2011 (Figure 2 B); i.e. 46.9 and 43.1% of patients whose treatment was intensified were intensified with bolus or premix insulin, respectively, and 10.0% of individuals were intensified with GLP‐1 RAs (data not shown).

also in 53,322 other papers